Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Kedudukan dalam Saham #33864
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Harga Saham
$0.5475
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$6.71M
Perubahan (1 hari)
5.57%
Perubahan (1 tahun)
-
Negara
US
Perdagangan 20/20 Biolabs Inc. (AIDX)

Kategori

Sejarah pecahan saham untuk 20/20 Biolabs Inc. (AIDX)
Saham 20/20 Biolabs Inc. (simbol: AIDX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 17, 2026.
Satu saham AIDX yang dibeli sebelum Aug 17, 2026 kini bersamaan dengan 0 saham AIDX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa